1 / 8

Cancer Biological Therapy Market to grow at 6% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2dppqXq <br>Novartis International Ag, Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG, Eli Lilly, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Celgene Corporation are some notable companies vying for global cancer biological therapy market share.

jueekate
Download Presentation

Cancer Biological Therapy Market to grow at 6% CAGR from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Biological Therapy Market to see growth of 6% from 2016 to 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from Cancer Biological Therapy Market: • Cancer Biological Therapy Market is estimated to cross USD 100 billion mark by 2023, by attaining a growth rate of 6% over 2016-2023. • Cancer is becoming a leading cause of death on a global scale, owing to which cancer biological therapy market has witnessed a significant surge over the recent years. • The growing geriatric population is more prone to cancer as per the statistics documented by ACS. Individuals aged 50 and above accounted for more than 86% of cases in the US. • This has considerably surged the global cancer biological therapy market share which was worth USD 61.3 billion in 2015. • Cancer biological therapy uses the body’s immune system to fight cancer or to lessen the side effects.

  3. Continued... • The antibody therapy has by far been the most thriving approach for the treatment of solid tumors and hematological malignancies. • The cancer vaccines market is also projected to grow at an annual rate of 17.2% over 2016-2023. • Japan contributes a major share in the Asia Pacific cancer biological therapy industry, subject to high prevalence of cancer in growing geriatric population base. • North America cancer biological therapy market is driven by a considerable increase in local and private funds for research and development activities. • Some of the key cancer biological therapy industry players include Bristol-Myers Squibb, Eli Lilly, Celgene Corporation, Seattle Genetics, Inc., Amgen Inc., GlaxoSmithKline Plc, Novartis International Ag, F. Hoffmann-La Roche AG, Spectrum Pharmaceuticals, Inc., and Merck & Co., Inc.

  4. U.S. Cancer Biological Therapy Market size, by product, 2012 - 2023 (USD Million)

  5. Browse Full Market Research Report On Cancer Biological Therapy Market @ http://bit.ly/2wktvCi Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/676https://www.gminsights.com/request-sample/detail/49

  6. Table of Content: Chapter 1 Methodology & Scope 1.1 Research Methodology 1.1.1 Initial data exploration 1.1.2 Statistical modeling and forecast 1.1.3 Industry insights and validation 1.2 Data Sources Chapter 2 Executive Summary 2.1 Cancer biologic therapy industry 3600 synopsis, 2012 - 2023 2.1.1 Business trends 2.1.2 Regional trends 2.1.3 Application trends

  7. Table of Content: Chapter 3 Cancer Biologic Therapy Industry Insights 3.1. Industry segmentation 3.2. Industry Size and forecast, 2012 - 2023 3.3. Industry Impact forces 3.3.1. Growth drivers 3.3.1.1. Increasing incidence of Cancer 3.3.1.2. Growing geriatric population 3.3.2. Industry pitfalls & challenges 3.3.2.1. High cost 3.3.2.2. Adverse effects of anti-cancer drug therapy 3.4. Regulatory landscape 3.5. Growth potential analysis 3.5.1. New business models 3.6. Technology & innovation trends 3.7. Porter’s analysis 3.8. PESTEL analysis 3.9. Competitive landscape, 2015

  8. Stay In Touch Website: www.gminsights.com Social Media:

More Related